FDA advisers review data on potential 1st US gene therapy

Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S.

The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp. The drugmaker is seeking approval to use the one-time treatment for children and young adults with advanced leukemia.

The therapy could be the first of a wave of cancer treatments custom-made to target a patient's cancer. Called CAR-T, it involves removing immune cells from a patients' blood, reprogramming them to create an army of attack cells and putting them back into the patient.

The panel is reviewing the safety, effectiveness and production of the treatment. It will vote on whether to recommend FDA approval.

Related News

Body donations on the rise at US medical schools

Aug 17, 2016

Many U.S. medical schools are seeing a surge in the number people leaving their bodies to science

'Auction' of NSA tools sends security companies scrambling

Aug 18, 2016

The leak of what purports to be a National Security Agency tool kit as part of a surreal online auction has set the information security world atwitter

'Mr. Robot' mobile game launches as phony messaging app

Aug 17, 2016

A fake messaging app inspired by the USA Network hacker 'Mr. Robot' was released Tuesday for mobile devices

About The Next Discovery

The Next Discovery is equipped with recent Science & Tech news to impart knowledge to individuals awaiting the future.

Contact us: sales@tndiscovery.com